29.09.2020 • News

WeylChem Appoints Johannes Kanellakopoulos as Head of Marketing & Sales Custom Manufacturing

WeylChem has appointed Johannes Kanellakopoulos as new Head of Marketing & Sales for its growing Custom Manufacturing business. He took over the role on Sept. 1 with the aim of fully exploiting the group's capabilities.

After studying chemistry in Germany and France and obtaining his PhD, Kanellakopoulos began his career in 1990 at Bayer as a lab manager in crop protection research. He first came into contact with custom manufacturing as plant manager in charge of piloting and initial production of customer-specific pharmaceutical intermediates. After further positions in marketing for exclusive synthesis, he became head of the newly created Global Strategic Sourcing unit in the Crop Protection division. When he moved to BASF, he took over the position of Head Sourcing & Contracting, where he was responsible for the global chemicals purchasing portfolio in the Agricultural Products division with a focus on outsourcing. Most recently, he was Manager Site Services at W.R. Grace’s site at Worms, Germany.

WeylChem has appointed Johannes Kanellakopoulos as new Head of Marketing &...
WeylChem has appointed Johannes Kanellakopoulos as new Head of Marketing & Sales for its growing Custom Manufacturing business. © WeylChem

Company

Logo:

WeylChem International GmbH

Alt-Fechenheim 34
60386 Frankfurt
Germany

Company contact







From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.